Therapeutic communities: AIDS/HIV risk and harm reduction

被引:6
作者
DeLeon, G
机构
[1] Ctr. for Therapeut. Comm. Research, Natl. Devmt./Res. Institutes, Inc., Two World Trade Center, New York
关键词
therapeutic community; HIV; drug abuse treatment; retention and motivation;
D O I
10.1016/S0740-5472(96)00118-3
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
The limited survey data available suggest that therapeutic communities have increasingly organized themselves to develop HN prevention programs and to integrate HIV-infected and AIDS clients into the treatment community while providing specialized program as necessary. Nonetheless, there remains a need for a comprehensive survey of the response of therapeutic communities to AIDS and the risk of HN infection. There is need as well for studies that can build on findings linking retention in the therapeutic community to strategies that focus on clients' motivation or readiness for treatment. In addition, therapeutic community programs can ally with outreach programs both to provide priority admission to seropositive clients, women with children, adolescents, and criminal justice clients, and to provide harm reduction services to those unwilling to enter treatment while also taking incremental steps to engage those clients in ever increasing behavior change initiatives. (C) 1996 Elsevier Science Inc.
引用
收藏
页码:411 / 420
页数:10
相关论文
共 37 条
[1]  
ANGLIN DM, 1990, DRUGS CRIME CRIME JU
[2]  
[Anonymous], NIDA RES MONOGRAPH
[3]  
[Anonymous], NIDA RES MONOGRAPH
[4]  
[Anonymous], 1989, Drug abuse treatment: A national study of effectiveness
[5]  
[Anonymous], J FLORIDA MED ASS
[6]  
BARTON E, 1994, P THER COMM AM 1992
[7]   MODIFYING THE PROCESS OF TREATMENT TO MEET THE THREAT OF AIDS [J].
BROWN, BS ;
NEEDLE, RH .
INTERNATIONAL JOURNAL OF THE ADDICTIONS, 1994, 29 (13) :1739-1752
[8]   FIXED AND DYNAMIC PREDICTORS OF CLIENT RETENTION IN THERAPEUTIC COMMUNITIES [J].
CONDELLI, WS ;
DELEON, G .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 1993, 10 (01) :11-16
[9]  
CONDELLI WS, 1994, NIDA RES MONOGRAPH, V144
[10]  
DELEON G, 1984, AM J DRUG ALCOHOL AB, V10, P267